One promising approach to treating type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can free patients from giving themselves frequent insulin injections ...
CHICAGO--(BUSINESS WIRE)--Sol-Millennium® Medical Group, manufacturer of medical devices, including syringes for medication delivery and testing, is proud to announce the launch of InsuJetâ„¢ ...
First self-administered, needle-free injection system approved by Health Canada gives access to safe, painless, cost-effective, and more sustainable drug delivery for chronic illnesses Toronto, ...
Ian Thompson, Vice-President of Account & Business Development at Ypsomed, takes us through the recent history of diabetes and obesity therapeutics, the innovative peptide hormone molecules that have ...
(A) Dynamics of the electrically induced microbubble, showing the formation, expansion, and shrinking of the microbubble and the shock wave and microjet from the microbubble. (B) Mechanism of the ...
Engineers designed an implantable device that carries hundreds of thousands of islet cells along with its own on-board oxygen factory to keep the cells healthy. Such a device could help Type 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results